Part 5/8:
Unfortunately, the anticipated benefits remained elusive, while side effects began to manifest. Reports of cankers, slow wound healing, and notable disruptions in cholesterol and blood glucose levels raised flags regarding the safety of the treatment. Most concerning was an increased resting heart rate, a critical biomarker that the narrator closely tracked.
Despite setbacks, the pursuit of longevity through rapamycin continued until a pivotal decision was made to pause the drug. Upon discontinuation, immediate improvements were noted in blood glucose levels, cholesterol alignment, and a reduction in soft tissue infections, suggesting the side effects were indeed linked to rapamycin.